Get ready, the F2I is back with € 130,000 to foster innovation at the UB!

At the Bosch i Gimpera Foundation we connect university
and business to transfer innovation to society

What we do

Contract Research

We provide customized research services for companies

Business Creation

We promote innovative new companies

Technologies, materials, and licences

We commercialize the technologies developed by researchers to make them available to companies

Who can benefit from our services

Researchers

We help you so that your research has an impact on society

Companies

We propose to improve the competitiveness of your business through innovation

Investors and mentors

We provide you with opportunities as an investor, business angel, or mentor

Results

667

companies and institutions innovate with us

29.4M€

for the UB in contracted revenue

1,929

active projects

The FBG in Figures >

Success Stories

A website to warn of the interactions derived from combining cardiovascular drugs with certain types of food

The professionals can search by therapeutic or drug group, food, medicinal plant or supplement

Virtual reality to increase empathy with victims

Participants enter the body of a woman who experiences a domestic aggression through glasses and an immersive virtual reality device

Atlas of Barcelona’s Nesting Birds

The project was born with the aim of mapping the location of the birds breeding both in Barcelona

More Success Stories >

News

Elena Lauroba «We have made it possible for people to live longer, but not necessarily better»

Dr. Elena Lauroba, from the Faculty of Law of the University of Barcelona, takes part in the study “Towards active...

Get ready, the F2I is back with € 130,000 to foster innovation at the UB!

Do you have an idea with a high transfer potential but you lack the resources to carry out a proof...

Promising family of compounds against multi-resistant bacteria

Infections caused by antibiotic resistant bacteria are difficult to treat, as they require expensive alternatives that entail side effects and...

More news >